img

Global Cannabis Use Disorder Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cannabis Use Disorder Treatment Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Cannabis Use Disorder Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cannabis Use Disorder Treatment market research.
Key companies engaged in the Cannabis Use Disorder Treatment industry include AbbVie, Alkermes, BioCorRx, Cipla Limited, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Limited, Indivior and Mallinckrodt, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cannabis Use Disorder Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cannabis Use Disorder Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cannabis Use Disorder Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AbbVie
Alkermes
BioCorRx
Cipla Limited
Dr. Reddy’s Laboratories
Glenmark Pharmaceuticals Limited
Intas Pharmaceuticals Limited
Indivior
Mallinckrodt
Noramco
Orexo AB
Purdue Pharma
Segment by Type
Tobacco/Nicotine and Vaping
Alcohol
Marijuana
Synthetic Cannabinoids
Others

Segment by Application


Hospitals and Clinics
Rehabilitation Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cannabis Use Disorder Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cannabis Use Disorder Treatment Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Tobacco/Nicotine and Vaping
1.2.3 Alcohol
1.2.4 Marijuana
1.2.5 Synthetic Cannabinoids
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cannabis Use Disorder Treatment Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Hospitals and Clinics
1.3.3 Rehabilitation Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cannabis Use Disorder Treatment Market Perspective (2024-2034)
2.2 Cannabis Use Disorder Treatment Growth Trends by Region
2.2.1 Global Cannabis Use Disorder Treatment Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Cannabis Use Disorder Treatment Historic Market Size by Region (2024-2024)
2.2.3 Cannabis Use Disorder Treatment Forecasted Market Size by Region (2024-2034)
2.3 Cannabis Use Disorder Treatment Market Dynamics
2.3.1 Cannabis Use Disorder Treatment Industry Trends
2.3.2 Cannabis Use Disorder Treatment Market Drivers
2.3.3 Cannabis Use Disorder Treatment Market Challenges
2.3.4 Cannabis Use Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cannabis Use Disorder Treatment Players by Revenue
3.1.1 Global Top Cannabis Use Disorder Treatment Players by Revenue (2024-2024)
3.1.2 Global Cannabis Use Disorder Treatment Revenue Market Share by Players (2024-2024)
3.2 Global Cannabis Use Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cannabis Use Disorder Treatment Revenue
3.4 Global Cannabis Use Disorder Treatment Market Concentration Ratio
3.4.1 Global Cannabis Use Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cannabis Use Disorder Treatment Revenue in 2022
3.5 Cannabis Use Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Cannabis Use Disorder Treatment Product Solution and Service
3.7 Date of Enter into Cannabis Use Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cannabis Use Disorder Treatment Breakdown Data by Type
4.1 Global Cannabis Use Disorder Treatment Historic Market Size by Type (2024-2024)
4.2 Global Cannabis Use Disorder Treatment Forecasted Market Size by Type (2024-2034)
5 Cannabis Use Disorder Treatment Breakdown Data by Application
5.1 Global Cannabis Use Disorder Treatment Historic Market Size by Application (2024-2024)
5.2 Global Cannabis Use Disorder Treatment Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Cannabis Use Disorder Treatment Market Size (2024-2034)
6.2 North America Cannabis Use Disorder Treatment Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Cannabis Use Disorder Treatment Market Size by Country (2024-2024)
6.4 North America Cannabis Use Disorder Treatment Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cannabis Use Disorder Treatment Market Size (2024-2034)
7.2 Europe Cannabis Use Disorder Treatment Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Cannabis Use Disorder Treatment Market Size by Country (2024-2024)
7.4 Europe Cannabis Use Disorder Treatment Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cannabis Use Disorder Treatment Market Size (2024-2034)
8.2 Asia-Pacific Cannabis Use Disorder Treatment Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2024-2024)
8.4 Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cannabis Use Disorder Treatment Market Size (2024-2034)
9.2 Latin America Cannabis Use Disorder Treatment Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Cannabis Use Disorder Treatment Market Size by Country (2024-2024)
9.4 Latin America Cannabis Use Disorder Treatment Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cannabis Use Disorder Treatment Market Size (2024-2034)
10.2 Middle East & Africa Cannabis Use Disorder Treatment Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2024-2024)
10.4 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Cannabis Use Disorder Treatment Introduction
11.1.4 AbbVie Revenue in Cannabis Use Disorder Treatment Business (2024-2024)
11.1.5 AbbVie Recent Development
11.2 Alkermes
11.2.1 Alkermes Company Detail
11.2.2 Alkermes Business Overview
11.2.3 Alkermes Cannabis Use Disorder Treatment Introduction
11.2.4 Alkermes Revenue in Cannabis Use Disorder Treatment Business (2024-2024)
11.2.5 Alkermes Recent Development
11.3 BioCorRx
11.3.1 BioCorRx Company Detail
11.3.2 BioCorRx Business Overview
11.3.3 BioCorRx Cannabis Use Disorder Treatment Introduction
11.3.4 BioCorRx Revenue in Cannabis Use Disorder Treatment Business (2024-2024)
11.3.5 BioCorRx Recent Development
11.4 Cipla Limited
11.4.1 Cipla Limited Company Detail
11.4.2 Cipla Limited Business Overview
11.4.3 Cipla Limited Cannabis Use Disorder Treatment Introduction
11.4.4 Cipla Limited Revenue in Cannabis Use Disorder Treatment Business (2024-2024)
11.4.5 Cipla Limited Recent Development
11.5 Dr. Reddy’s Laboratories
11.5.1 Dr. Reddy’s Laboratories Company Detail
11.5.2 Dr. Reddy’s Laboratories Business Overview
11.5.3 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Introduction
11.5.4 Dr. Reddy’s Laboratories Revenue in Cannabis Use Disorder Treatment Business (2024-2024)
11.5.5 Dr. Reddy’s Laboratories Recent Development
11.6 Glenmark Pharmaceuticals Limited
11.6.1 Glenmark Pharmaceuticals Limited Company Detail
11.6.2 Glenmark Pharmaceuticals Limited Business Overview
11.6.3 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Introduction
11.6.4 Glenmark Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2024-2024)
11.6.5 Glenmark Pharmaceuticals Limited Recent Development
11.7 Intas Pharmaceuticals Limited
11.7.1 Intas Pharmaceuticals Limited Company Detail
11.7.2 Intas Pharmaceuticals Limited Business Overview
11.7.3 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Introduction
11.7.4 Intas Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2024-2024)
11.7.5 Intas Pharmaceuticals Limited Recent Development
11.8 Indivior
11.8.1 Indivior Company Detail
11.8.2 Indivior Business Overview
11.8.3 Indivior Cannabis Use Disorder Treatment Introduction
11.8.4 Indivior Revenue in Cannabis Use Disorder Treatment Business (2024-2024)
11.8.5 Indivior Recent Development
11.9 Mallinckrodt
11.9.1 Mallinckrodt Company Detail
11.9.2 Mallinckrodt Business Overview
11.9.3 Mallinckrodt Cannabis Use Disorder Treatment Introduction
11.9.4 Mallinckrodt Revenue in Cannabis Use Disorder Treatment Business (2024-2024)
11.9.5 Mallinckrodt Recent Development
11.10 Noramco
11.10.1 Noramco Company Detail
11.10.2 Noramco Business Overview
11.10.3 Noramco Cannabis Use Disorder Treatment Introduction
11.10.4 Noramco Revenue in Cannabis Use Disorder Treatment Business (2024-2024)
11.10.5 Noramco Recent Development
11.11 Orexo AB
11.11.1 Orexo AB Company Detail
11.11.2 Orexo AB Business Overview
11.11.3 Orexo AB Cannabis Use Disorder Treatment Introduction
11.11.4 Orexo AB Revenue in Cannabis Use Disorder Treatment Business (2024-2024)
11.11.5 Orexo AB Recent Development
11.12 Purdue Pharma
11.12.1 Purdue Pharma Company Detail
11.12.2 Purdue Pharma Business Overview
11.12.3 Purdue Pharma Cannabis Use Disorder Treatment Introduction
11.12.4 Purdue Pharma Revenue in Cannabis Use Disorder Treatment Business (2024-2024)
11.12.5 Purdue Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cannabis Use Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Tobacco/Nicotine and Vaping
Table 3. Key Players of Alcohol
Table 4. Key Players of Marijuana
Table 5. Key Players of Synthetic Cannabinoids
Table 6. Key Players of Others
Table 7. Global Cannabis Use Disorder Treatment Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 8. Global Cannabis Use Disorder Treatment Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 9. Global Cannabis Use Disorder Treatment Market Size by Region (2024-2024) & (US$ Million)
Table 10. Global Cannabis Use Disorder Treatment Market Share by Region (2024-2024)
Table 11. Global Cannabis Use Disorder Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 12. Global Cannabis Use Disorder Treatment Market Share by Region (2024-2034)
Table 13. Cannabis Use Disorder Treatment Market Trends
Table 14. Cannabis Use Disorder Treatment Market Drivers
Table 15. Cannabis Use Disorder Treatment Market Challenges
Table 16. Cannabis Use Disorder Treatment Market Restraints
Table 17. Global Cannabis Use Disorder Treatment Revenue by Players (2024-2024) & (US$ Million)
Table 18. Global Cannabis Use Disorder Treatment Market Share by Players (2024-2024)
Table 19. Global Top Cannabis Use Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis Use Disorder Treatment as of 2022)
Table 20. Ranking of Global Top Cannabis Use Disorder Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Cannabis Use Disorder Treatment Revenue (CR5 and HHI) & (2024-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cannabis Use Disorder Treatment Product Solution and Service
Table 24. Date of Enter into Cannabis Use Disorder Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cannabis Use Disorder Treatment Market Size by Type (2024-2024) & (US$ Million)
Table 27. Global Cannabis Use Disorder Treatment Revenue Market Share by Type (2024-2024)
Table 28. Global Cannabis Use Disorder Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 29. Global Cannabis Use Disorder Treatment Revenue Market Share by Type (2024-2034)
Table 30. Global Cannabis Use Disorder Treatment Market Size by Application (2024-2024) & (US$ Million)
Table 31. Global Cannabis Use Disorder Treatment Revenue Market Share by Application (2024-2024)
Table 32. Global Cannabis Use Disorder Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 33. Global Cannabis Use Disorder Treatment Revenue Market Share by Application (2024-2034)
Table 34. North America Cannabis Use Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 35. North America Cannabis Use Disorder Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 36. North America Cannabis Use Disorder Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 37. Europe Cannabis Use Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 38. Europe Cannabis Use Disorder Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 39. Europe Cannabis Use Disorder Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 40. Asia-Pacific Cannabis Use Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 41. Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2024-2024) & (US$ Million)
Table 42. Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 43. Latin America Cannabis Use Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 44. Latin America Cannabis Use Disorder Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 45. Latin America Cannabis Use Disorder Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 46. Middle East & Africa Cannabis Use Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 47. Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 48. Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 49. AbbVie Company Detail
Table 50. AbbVie Business Overview
Table 51. AbbVie Cannabis Use Disorder Treatment Product
Table 52. AbbVie Revenue in Cannabis Use Disorder Treatment Business (2024-2024) & (US$ Million)
Table 53. AbbVie Recent Development
Table 54. Alkermes Company Detail
Table 55. Alkermes Business Overview
Table 56. Alkermes Cannabis Use Disorder Treatment Product
Table 57. Alkermes Revenue in Cannabis Use Disorder Treatment Business (2024-2024) & (US$ Million)
Table 58. Alkermes Recent Development
Table 59. BioCorRx Company Detail
Table 60. BioCorRx Business Overview
Table 61. BioCorRx Cannabis Use Disorder Treatment Product
Table 62. BioCorRx Revenue in Cannabis Use Disorder Treatment Business (2024-2024) & (US$ Million)
Table 63. BioCorRx Recent Development
Table 64. Cipla Limited Company Detail
Table 65. Cipla Limited Business Overview
Table 66. Cipla Limited Cannabis Use Disorder Treatment Product
Table 67. Cipla Limited Revenue in Cannabis Use Disorder Treatment Business (2024-2024) & (US$ Million)
Table 68. Cipla Limited Recent Development
Table 69. Dr. Reddy’s Laboratories Company Detail
Table 70. Dr. Reddy’s Laboratories Business Overview
Table 71. Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Product
Table 72. Dr. Reddy’s Laboratories Revenue in Cannabis Use Disorder Treatment Business (2024-2024) & (US$ Million)
Table 73. Dr. Reddy’s Laboratories Recent Development
Table 74. Glenmark Pharmaceuticals Limited Company Detail
Table 75. Glenmark Pharmaceuticals Limited Business Overview
Table 76. Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product
Table 77. Glenmark Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2024-2024) & (US$ Million)
Table 78. Glenmark Pharmaceuticals Limited Recent Development
Table 79. Intas Pharmaceuticals Limited Company Detail
Table 80. Intas Pharmaceuticals Limited Business Overview
Table 81. Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product
Table 82. Intas Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2024-2024) & (US$ Million)
Table 83. Intas Pharmaceuticals Limited Recent Development
Table 84. Indivior Company Detail
Table 85. Indivior Business Overview
Table 86. Indivior Cannabis Use Disorder Treatment Product
Table 87. Indivior Revenue in Cannabis Use Disorder Treatment Business (2024-2024) & (US$ Million)
Table 88. Indivior Recent Development
Table 89. Mallinckrodt Company Detail
Table 90. Mallinckrodt Business Overview
Table 91. Mallinckrodt Cannabis Use Disorder Treatment Product
Table 92. Mallinckrodt Revenue in Cannabis Use Disorder Treatment Business (2024-2024) & (US$ Million)
Table 93. Mallinckrodt Recent Development
Table 94. Noramco Company Detail
Table 95. Noramco Business Overview
Table 96. Noramco Cannabis Use Disorder Treatment Product
Table 97. Noramco Revenue in Cannabis Use Disorder Treatment Business (2024-2024) & (US$ Million)
Table 98. Noramco Recent Development
Table 99. Orexo AB Company Detail
Table 100. Orexo AB Business Overview
Table 101. Orexo AB Cannabis Use Disorder Treatment Product
Table 102. Orexo AB Revenue in Cannabis Use Disorder Treatment Business (2024-2024) & (US$ Million)
Table 103. Orexo AB Recent Development
Table 104. Purdue Pharma Company Detail
Table 105. Purdue Pharma Business Overview
Table 106. Purdue Pharma Cannabis Use Disorder Treatment Product
Table 107. Purdue Pharma Revenue in Cannabis Use Disorder Treatment Business (2024-2024) & (US$ Million)
Table 108. Purdue Pharma Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cannabis Use Disorder Treatment Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Cannabis Use Disorder Treatment Market Share by Type: 2022 VS 2034
Figure 3. Tobacco/Nicotine and Vaping Features
Figure 4. Alcohol Features
Figure 5. Marijuana Features
Figure 6. Synthetic Cannabinoids Features
Figure 7. Others Features
Figure 8. Global Cannabis Use Disorder Treatment Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Cannabis Use Disorder Treatment Market Share by Application: 2022 VS 2034
Figure 10. Hospitals and Clinics Case Studies
Figure 11. Rehabilitation Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Cannabis Use Disorder Treatment Report Years Considered
Figure 14. Global Cannabis Use Disorder Treatment Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 15. Global Cannabis Use Disorder Treatment Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 16. Global Cannabis Use Disorder Treatment Market Share by Region: 2022 VS 2034
Figure 17. Global Cannabis Use Disorder Treatment Market Share by Players in 2022
Figure 18. Global Top Cannabis Use Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis Use Disorder Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Cannabis Use Disorder Treatment Revenue in 2022
Figure 20. North America Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 21. North America Cannabis Use Disorder Treatment Market Share by Country (2024-2034)
Figure 22. United States Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. Canada Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. Europe Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. Europe Cannabis Use Disorder Treatment Market Share by Country (2024-2034)
Figure 26. Germany Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. France Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. U.K. Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Italy Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Russia Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Nordic Countries Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Asia-Pacific Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. Asia-Pacific Cannabis Use Disorder Treatment Market Share by Region (2024-2034)
Figure 34. China Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. Japan Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. South Korea Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Southeast Asia Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. India Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Australia Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Latin America Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Latin America Cannabis Use Disorder Treatment Market Share by Country (2024-2034)
Figure 42. Mexico Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Brazil Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Middle East & Africa Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. Middle East & Africa Cannabis Use Disorder Treatment Market Share by Country (2024-2034)
Figure 46. Turkey Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 47. Saudi Arabia Cannabis Use Disorder Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 48. AbbVie Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2024-2024)
Figure 49. Alkermes Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2024-2024)
Figure 50. BioCorRx Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2024-2024)
Figure 51. Cipla Limited Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2024-2024)
Figure 52. Dr. Reddy’s Laboratories Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2024-2024)
Figure 53. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2024-2024)
Figure 54. Intas Pharmaceuticals Limited Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2024-2024)
Figure 55. Indivior Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2024-2024)
Figure 56. Mallinckrodt Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2024-2024)
Figure 57. Noramco Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2024-2024)
Figure 58. Orexo AB Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2024-2024)
Figure 59. Purdue Pharma Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2024-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed